During the past decade, ECHO Confluent conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ECHO Confluent" #1 collaborator was "Central Hospital, Nancy, France" with 1 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "ECHO Confluent" are "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "Autosomal Dominant Polycystic Kidney Disease (ADPKD)" (1 trials), "Chronic Renal Failure" (1 trials) and "End Stage Renal Failure on Dialysis" (1 trials). Many other conditions were trialed in "ECHO Confluent" in a lesser frequency.

Most popular intervention types in "ECHO Confluent" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Collection" (1 trials), "Non-interventional study" (1 trials), "Placebo" (1 trials) and "Spironolactone" (1 trials). Other intervention names were less common.

The vast majority of trials in "ECHO Confluent" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ECHO Confluent". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ECHO Confluent, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ECHO Confluent, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".